We’re glad to see you’re enjoying ReachMD…but how about a more personalized experience?
Danielle Becker, MD, MS, FAES
Ahmed Abdelmoity, MD
Deborah Holder, MD
John Stern, MD
Titrating and Dosing Device Therapy for DRE: Best Practices for Optimizing Patient Outcomes
John D. Mahan, MD
Guido Filler, MD, PhD, FRCPC
Maria E. Díaz-González de Ferris, MD, MPH, PhD
Anne E. Dawson, PhD
From Child to Adult: Successful Transitional Care for X-Linked Hypophosphatemia
Individualized Treatment Approaches for Optimal Lifelong Management of Children and Adults with XLH
Pediatric To Adult Care: A Team Effort
XLH: A Case of Bowed Legs - What Else Could It Be?
XLH: An Uncommon But Treatable Disorder
Best Practice for the Multidisciplinary Team – Starting Transition Early, Tailoring the Specific Timing and Speed to Individual Patients
Continuing XLH Treatment into Adulthood – Evolving the Treatment Goals
Healthcare Transition with XLH
Psychosocial Considerations in Managing XLH
Kara B. Markham, MD
Hemolytic Disease of the Fetus and Newborn (HDFN): What Pediatric Providers Need to Know When Managing Hemolytic Disease in Newborns (HDN)
William Mencia, MD, FACEHP, CHCP
Julie Blatt, MD
Taizo Nakano, MD
Evolving Perspectives in PIK3CA-related Overgrowth Spectrum Diagnosis & Treatment
Riten Kumar, MD, MSc
What Do the Current Clinical Guidelines Recommend Regarding Post-acute Management of VTE in Pediatric Patients?
What Therapeutic Options Are Currently Available for Post-acute Anticoagulation Therapy To Prevent Recurrent VTE in Pediatric Patients?
Julie Jaffray, MD, MS
The Prevalence and Severity of Recurrent VTE in Children
Press cancel to remain on ReachMD. Press the link below or the continue button to keep going.
Stay current with the best on medical education